Skybound is a founder-led venture capital fund investing at pre-seed and seed in deep tech, climate, AI, and frontier innovation. Global vision, European roots.
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed
Mentions in press and media 7
| Date | Title | Description |
| 23.05.2026 | Neurosoft Bioelectronics Fuels BCI Revolution with $7.5M Funding | Neurosoft Bioelectronics closed a $7.5 million seed round. This significant funding accelerates revolutionary stretchable brain-computer interfaces (BCIs). These minimally invasive devices offer unparalleled compliance and extensive cortica... |
| 22.05.2026 | CEE Startup & Tech Weekly: New Deep Tech VC Launches | Company: The Recursive’s weekly roundup aims to cover key tech developments across Central and Eastern Europe, as well as the growing impact of CEE-born founders on the global stage. Take a look at the latest news in funding, startup milest... |
| 22.05.2026 | Neurosoft Bioelectronics: $7.5 Million Seed Round Closed To Advance Stretchable Brain-Computer Interfaces | Neurosoft Bioelectronics announced it has closed a $7.5 million oversubscribed seed financing round to accelerate development of its stretchable and scalable brain-computer interface (BCI) platform. The funding will support the company’s mi... |
| 20.05.2026 | Neurosoft Bioelectronics raises $7.5M for scalable brain-computer interfaces | Neurosoft Bioelectronics, a neurotechnology company developing scalable and minimally invasive brain-computer interfaces (BCIs), has raised $7.5 million in an oversubscribed seed funding round led by Skybound Venture Capital, with participa... |
| 20.05.2026 | Skybound launches with $38M to back early deeptech founders | Skybound Venture Capital has announced the launch of its founder-led venture capital fund focused on deeptech startups, securing a $38 million oversubscribed first close anchored by the European Investment Fund. Based in Athens, Skybound wa... |
| 20.05.2026 | Neurosoft Bioelectronics Raises $7.5M in Seed Funding | Neurosoft Bioelectronics, a Geneva, Switzerland- and NYC-based neurotechnology company developing soft brain-computer interfaces (BCIs), raised $7.5M in Seed funding. The round was led by Skybound Venture Capital with participation from PL ... |
| 20.05.2026 | Neurosoft Bioelectronics Closes $7.5M Oversubscribed Seed Round | Neurosoft’s platform enables access to the full cortex without penetrating brain tissue. Its proprietary soft, stretchable electrodes are up to 1,000 times more compliant than those used in other flexible neural interfaces, cover up to 30x... |